CABOZANTINIB S-MALATE for Off label use: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 193 adverse event reports in the FDA FAERS database where CABOZANTINIB S-MALATE was used for Off label use.
Most Reported Side Effects for CABOZANTINIB S-MALATE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 8,282 | 21.1% | 315 | 1,313 |
| Fatigue | 6,819 | 17.4% | 261 | 897 |
| Off label use | 5,245 | 13.4% | 591 | 633 |
| Nausea | 4,341 | 11.1% | 175 | 736 |
| Decreased appetite | 4,076 | 10.4% | 233 | 751 |
| Blood pressure increased | 2,939 | 7.5% | 63 | 416 |
| Malignant neoplasm progression | 2,718 | 6.9% | 909 | 626 |
| Palmar-plantar erythrodysaesthesia syndrome | 2,706 | 6.9% | 119 | 349 |
| Weight decreased | 2,657 | 6.8% | 139 | 462 |
| Stomatitis | 2,560 | 6.5% | 91 | 347 |
| Death | 2,504 | 6.4% | 2,497 | 368 |
| Constipation | 2,098 | 5.3% | 91 | 359 |
| Blister | 1,943 | 5.0% | 27 | 150 |
| Vomiting | 1,870 | 4.8% | 113 | 491 |
| Taste disorder | 1,851 | 4.7% | 43 | 236 |
Other Indications for CABOZANTINIB S-MALATE
Renal cancer (15,186)
Renal cell carcinoma (9,156)
Product used for unknown indication (3,104)
Hepatocellular carcinoma (2,670)
Thyroid cancer (1,615)
Metastatic renal cell carcinoma (1,055)
Metastases to lung (727)
Clear cell renal cell carcinoma (704)
Metastases to bone (514)
Hepatic cancer (508)
Other Drugs Used for Off label use
LENALIDOMIDE (5,767)
ECULIZUMAB (3,550)
CERTOLIZUMAB PEGOL (2,256)
ABOBOTULINUMTOXINA (2,170)
LEVETIRACETAM (2,161)
APREMILAST (1,995)
PROPRANOLOL (1,576)
CETIRIZINE (1,416)
HUMAN IMMUNOGLOBULIN G (1,129)
THALIDOMIDE (1,033)